Daniel Bryan Goodman
@dbgoodman.bsky.social
Assistant Professor at UPenn. Synthetic immunologist & computational biologist. Using DNA synth, multiplex assays and generative models to understand & engineer immune cell signaling & function. Church lab alum.
Web: www.dbgoodman.com
Web: www.dbgoodman.com
Reposted by Daniel Bryan Goodman
AAV opens up the 80% of genome considered 'undruggable'. A key challenge and opportunity is to search that space for the right targets. Manufacturing capacity is sufficient to serve tens of millions of patients at safe doses, as long as we can find the right targets for efficacy.
March 20, 2025 at 2:29 PM
AAV opens up the 80% of genome considered 'undruggable'. A key challenge and opportunity is to search that space for the right targets. Manufacturing capacity is sufficient to serve tens of millions of patients at safe doses, as long as we can find the right targets for efficacy.
Reposted by Daniel Bryan Goodman
*dusting off hands* ah yes that should do it
March 18, 2025 at 5:26 AM
*dusting off hands* ah yes that should do it
There's also LB buffer: en.m.wikipedia.org/wiki/LB_buffer
November 2, 2023 at 11:45 PM
There's also LB buffer: en.m.wikipedia.org/wiki/LB_buffer
Reposted by Daniel Bryan Goodman
Institute for Human Genetics (IHG) has multiple faculty positions open! We are looking for folks at any level, and across the range of the genetics/genomics spectrum! I chair the search for computational folks in stat or pop gen! Looking to welcome you!! aprecruit.ucsf.edu/JPF04729
October 6, 2023 at 4:39 AM
Institute for Human Genetics (IHG) has multiple faculty positions open! We are looking for folks at any level, and across the range of the genetics/genomics spectrum! I chair the search for computational folks in stat or pop gen! Looking to welcome you!! aprecruit.ucsf.edu/JPF04729